Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-012120

SVP & Chief Commercial Officer sold 15,358 shares at $22.37 ($343,558)

From the SEC's structured data for this filing

Trades in this filing

NORTHCOTT JOHN · SVP & Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-02-16 Sale : show line 1 in the form −15,358 $22.37 $343,558 213,192 D
Open-market sales · 15,358 sh · avg $22.37 · $343,558
Loading xslF345X03/doc4.xml…